ADAMTS13 and hemolytic-uremic syndrome: This entity is increasingly identified in critically ill pediatric patients with signs consistent with TTP/HUS, but without significant hemolysis as seen by rare schistocytes, normal haptoglobin, and mildly suppressed ADAMTS13 activity.